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AbstrAct
Objectives To evaluate the feasibility and potential clinical 
benefits of medicines optimisation through comprehensive 
geriatric assessment (CGA) of frail patients with multiple 
conditions, by secondary care geriatricians in a general 
practice care setting.
Methods Seven general practitioner (GP) practices 
in one region of Stoke-on-Trent volunteered to take 
part. GPs selected patients (n=186) who were local 
permanent residents, at least 65 years old and on eight 
or more medications per day. Patients were sent a written 
invitation outlining the assessment purpose/format. Prior 
to patient assessments, primary care staff prepared packs 
detailing patient medical history, recent consultations, 
current medications, recent laboratory tests and social 
circumstances. One hour was allocated for the CGA per 
patient, with one of three geriatricians, to enable sufficient 
time to explore all relevant aspects. Assessment comprised 
a full history, thorough clinical examination, assessment 
of balance and mobility, mental function and information 
on home environment and support arrangements. After 
consultation, geriatricians made recommendations 
regarding further assessments, investigations or medication 
changes. Geriatricians entered their main findings and 
recommendations onto a standard template.
results In total, 687 recommendations for changes in 
patients’ medication regimens were made for 169 (91%) 
patients. In 17 (9%) patients there was no recommendation 
to alter medications. This resulted in an average of four 
alterations in medication per patient. The predominant 
changes to medications were to stop medications (34%) 
or to reduce the dosage (24%). Starting a new medication 
represented 18% of all the medication changes. Adherence 
rates to geriatrician medication recommendations were 72% 
at 6 months and 65% at 12 months.
conclusions CGA of older patients with complex 
needs, by geriatricians in a general practice care 
setting, is feasible. Our study demonstrated constructive 
collaboration between GPs and geriatricians from 
secondary care, suggesting further studies and clinical 
trials are feasible and have scope to yield beneficial 
outcomes.
IntrOductIOn
We live in an increasingly ageing population, 
with the fastest population increases being in 
those aged 85 years and over. It is projected 
that by 2035, people aged 65 years and over 
will account for 23% of the population as 
compared with 17% in 2010.1 The health and 
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strengths and limitations of this study
 ► We did not have an independent control group of 
patients with which to compare the effect of the 
comprehensive geriatric assessment (CGA). Instead, 
we relied on patients who received a CGA to be 
their own controls (comparing healthcare usage 12 
months pre-CGA and post-CGA intervention for each 
patient).
 ► By using patient medication information from 
geriatricians’ records, it enabled us to record data 
relating to patient medications, medication changes 
and adherence to medication changes after CGA.
 ► The study was limited to one area of Stoke-on-Trent. 
Hence, the results cannot be readily extrapolated to 
other areas in North Staffordshire or elsewhere.
 ► As this was a study to assess the feasibility of 
undertaking a service redesign, the number of 
subjects was modest.
 ► Further investigation is necessary to understand 
why some practices did not want to be involved 
in the study and what could be done to increase 
participation. This may impact on wide scale 
generalisability.
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social care of older people can often be complex due to 
frailty, multimorbidity, cognitive impairment, functional 
limitations and diverse care needs.2
Recent estimates suggest that 16% of adult patients 
in England have more than one of the long-term condi-
tions outlined in the Quality and Outcomes Framework 
and these patients account for 32% of all consultations 
in general practice.3 Wallace et al4 summarised a number 
of key issues in managing older patients with multimor-
bidity in primary care. They included fragmentation and 
poor coordination of care, troublesome polypharmacy, 
reduced quality of life and increased healthcare usage. 
The complexity of these patients provides real chal-
lenges as clinical care teams are aiming to manage several 
coexisting and interacting chronic conditions with the 
prevailing model of single-disease clinical guidelines. 
Guidelines rarely deal with multimorbidity, and research 
studies have often included few or no frail older patients.5
A recent study of adults in primary care reported that 
21% of patients with two long-term conditions were 
prescribed four to nine drugs and 1% were prescribed 10 
or more medications. For patients with at least six condi-
tions, these rates increased to 47% and 41%, respectively.6 
It is recognised that unnecessary and inappropriate 
prescribing are associated with more adverse drug events 
and reduced well-being as well as increased healthcare 
usage and hospitalisations.7
There is a desire to deliver high-quality healthcare closer 
to home, thus relieving the demand on hard-pressed 
secondary care services, and to manage patients where it 
is more convenient and preferable for patients and their 
carers. This includes a greater amount of preventative 
and proactive care of long-term conditions and requires 
the deployment of multidisciplinary and multiprofes-
sional care teams and innovative working practices.8 9
Comprehensive geriatric assessment (CGA) has been 
defined as ‘a multidimensional interdisciplinary diag-
nostic process focused on determining a frail elderly 
person’s medical, psychological and functional capability 
in order to develop a coordinated and integrated plan 
for treatment and long-term follow-up’.2 Ellis and Lang-
horne further defined frailty as a reduced ability to with-
stand illness without loss of function because of the effects 
of the ageing process, presence of chronic conditions, 
functional impairments and dependence on others.2 
Randomised controlled trials (RCTs) have shown that 
CGA and individualised multidisciplinary interventions 
reduce the rate of functional decline, decrease admis-
sions to hospital and to institutional care, and prolong 
survival.10 11
This project focused on frail patients with long-term 
conditions living in the community and aimed to eval-
uate the role of geriatricians in supporting their clinical 
management within primary care. Since we were unaware 
of any literature reporting the use of secondary care geri-
atricians in the general practice care setting, we wished 
to undertake a pilot to assess the willingness of general 
practitioners (GPs) and patients to engage with the 
project and any barriers that would prevent their recruit-
ment. Furthermore, we needed to determine whether it 
would be possible to collect data relating to each patient’s 
current medications and the medication changes recom-
mended by the geriatricians. We also wished to assess 
whether it would be possible to evaluate adherence to 
medication recommendations.
MethOds
Objectives
The main objective of this study was to evaluate the feasi-
bility of undertaking a service redesign where secondary 
care geriatricians worked in the general practice care 
setting. A secondary objective was to gain insight into 
the potential clinical benefits of medicines optimisation 
through CGA of frail patients with multiple conditions. 
Furthermore, we aimed to determine whether data 
collection and analysis were feasible. It was also expected 
that data generated during this study would be useful in 
planning a comparative RCT.
study venue
All 17 general practices in 1 region of Stoke-on-Trent, 
North Staffordshire, UK were invited to participate. 
Of these, seven practices (41%) with patient popula-
tions of >5000 volunteered to take part. They included 
some of the most deprived wards in the city. Each prac-
tice had an overall average attainment in Quality and 
Outcomes Framework cardiovascular/diabetes indica-
tors as compared with the average attainment by all 54 
practices in Stoke-on-Trent clinical commissioning group 
(CCG). A CGA was carried out by geriatricians in clinics 
within the general practice surgeries, at home visits or in 
patients’ residential care or nursing home settings.
Ethical approval was not required as this project was 
not research, but an evaluation of the feasibility of service 
redesign, endorsed by the Stoke-on-Trent CCG, including 
the Caldicott Guardian who oversees any research and 
development with which the CCG is associated or has 
commissioned.
Patient selection
Patients were selected for the study by the GPs. A search 
of each participating general practice clinical computer 
system was performed to identify local permanent resi-
dents who were at least 65 years old and were on eight 
or more medications per day. There were two advantages 
to choosing the simple criterion of ≥8 medications: (1) 
patients on multiple medications may be receiving inap-
propriate polypharmacy and could have scope for optimi-
sation and (2) there is a strong association between the 
number of medications and degree of multimorbidity.12
Some patients ≥65 years with less than eight medica-
tions were also considered for inclusion at the discre-
tion of their GPs if they felt that it would enhance their 
well-being and quality of life, for example, patients 
with unstable long-term conditions or at high risk of 
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Table 1 Age and gender of patients who underwent 
assessment
Gender Number (%)
Median age 
(years)
Age range 
(years)
Male 76 (41) 78 66–93
Female 110 (59) 82 65–99
complications, deterioration or hospital admission. 
Patients were excluded if they had been under the care 
of a geriatrician or psychogeriatrician in the previous 
6 months as they would have already undergone holistic 
assessment and interventions. Temporary residents were 
also excluded as it would be difficult to follow them up 
and access their medical records.
From the initial list of patients that was generated in 
each practice, GPs selected the maximum number that 
could be accommodated in the planned geriatrician 
sessions that were allocated to each general practice 
surgery. In their selection of patients, GPs subjectively 
gave priority to those who they felt had the greatest needs 
and were likely to benefit the most. Patients were sent a 
written invitation outlining the purpose and format of the 
assessment and patients who accepted the offer were then 
allocated an appointment.
Geriatricians
Three geriatricians took part, including a local commu-
nity consultant geriatrician and two specialist registrars. 
The latter were in the final year of their geriatric medi-
cine training and were about to take up consultant geri-
atrician posts. The input of all three geriatricians to this 
study was on a part-time/sessional basis.
Assessment process
Prior to the patient assessments taking place, the primary 
care staff prepared a succinct pack incorporating each 
patient’s medical history, recent consultations, current 
medications, recent laboratory tests and social circum-
stances. One hour was allocated per patient for the CGA 
to enable the geriatrician sufficient time to explore all 
relevant aspects. On a typical day of consultations, a geri-
atrician carried out a CGA on six patients.
The assessment comprised a full history, thorough 
clinical examination, assessment of balance and 
mobility, mental function and information on home 
environment and support arrangements. At the end of 
each consultation the geriatricians made recommenda-
tions regarding further assessments (eg, physiotherapy, 
occupational therapy, other specialist input), investiga-
tions or medication changes. Geriatricians entered the 
main findings, conclusions and their recommendations 
onto a standard template. Additionally, a comprehen-
sive typed report was later sent to each patient’s GP. 
Both of these documents were used subsequently for 
data analysis and evaluation of the service. At the end of 
each consultation, patients were asked to comment on 
the usefulness of the consultation. At the end of each 
day of assessments, the geriatrician met with the rele-
vant GPs for 1–1.5 hours to outline every patient seen 
that day, discuss the rationale of the recommendations 
made, and give GPs an opportunity to comment on the 
usefulness of the assessments.
The geriatricians did not arrange to see the patients 
again and it was the remit of GPs to implement the 
recommendations and monitor progress. However, the 
geriatricians remained available for advice at any time 
afterwards by phone or email at the discretion of the GPs.
The research team subsequently reviewed the patients’ 
documentation to determine whether the general prac-
tice teams acted on the geriatrician recommendations 
and interventions.
Follow-up
Patients were reanalysed 6 and 12 months after assessment 
by collecting data on whether patients were receiving the 
geriatrician-recommended medications, the numbers of 
health-related episodes and usage of health services, and 
residency status. The health episodes and use of services 
included were: GP consultations, visits by community 
matrons, diabetes or specialist nurses from other depart-
ments, physiotherapy or other remedial therapy sessions, 
health checks, hospital outpatient clinics, appointments 
for hospital-based procedures, telephone calls to GP 
surgeries for advice, GP home visits, A&E department 
attendances, visits to the local walk-in primary care assess-
ment centre and hospital admissions.
data collection and statistical methods
In order to enable comparisons over time, the same types 
of data for the 12 months prior to the CGA were also 
collected (‘baseline’ data), grouped over two 6-month 
periods. The completeness of the data collected was 
dependent on the level of detail that the GP practice IT 
systems provided. The IT systems used at the GP practices 
included EMIS LV, EMIS Web and SystmOne. Statistical 
analysis was carried out using the SAS statistical package, 
V.9.3. For this pilot study, primarily descriptive statistics 
are presented, based on data type (means and SD for 
normally distributed variables, medians and IQRs for 
skewed variables and number and proportions for binary 
variables). Comparisons of counts before and after the 
intervention, for both planned and unplanned hospital 
admissions, were analysed using conditional negative 
binomial regression. Estimates of incident rate ratios 
(IRRs) and associated 95% CIs were presented. p Values 
were not presented as this was not a hypothesis-testing 
exercise.
results
The holistic assessments by the three geriatricians were 
performed in early 2014. A total of 186 patients were 
assessed, 110 (59%) were women and 76 (41%) men. 
Their median age was 81 years (range: 65–99) and women 
were significantly older than men (p<0.05) as shown in 
4 Lea SC, et al. BMJ Open 2017;7:e015278. doi:10.1136/bmjopen-2016-015278
Open Access 
Table 2 Geriatricians’ medication recommendations following assessment
Changes Occurrence
Changes per participant 
(mean)
% of 
participants
% of total medication 
changes
Start medication 122 0.7 44 18
Stop medication 232 1.4 71 34
Increase medication 55 0.3 25 8
Decrease medication 188 1.1 66 27
Change to alternative 90 0.5 35 13
Total 687 4 100
table 1. One hundred and forty patients (75%) lived at 
home and 46 (25%) lived in a residential care or nursing 
home. Of the patients who lived at home, 84 (45%) were 
cohabiting and 56 (30%) lived alone. One hundred and 
twenty-three (66%) of the patients were assessed by the 
community consultant geriatrician, and 33 (18%) and 30 
(16%) by the two specialist registrars, respectively.
Geriatricians’ recommendations for medicines optimisation
In total, 687 recommendations for changes in patients’ 
medication regimens were made for 169 (91%) patients. 
In 17 (9%) patients there was no recommendation to 
alter medications. Changes in patients’ medication are 
itemised in table 2. This resulted in an average of four 
changes in medication per patient. By far the predom-
inant changes to medications were to stop medications 
(34%) or to reduce the dosage (24%), which together 
accounted for 58% of all medication changes. Starting a 
new medication represented 122 (18%) of all the medica-
tion changes. In seven patients, the geriatricians recom-
mended consideration for a Do Not Attempt Resuscitation 
agreement to be implemented.
Feedback
All of the GPs involved in the project, who met the geri-
atricians to discuss their patients’ assessments, were posi-
tive about this pilot project and felt that their patients 
benefited clinically and that the presence of geriatricians 
in primary care was constructive and worthwhile. They 
further reported that their patients were pleased about 
the specialist community-based assessment by the geria-
tricians and felt that they benefited or that they were at 
least reassured. We received no unfavourable comments.
Follow-up analysis
By 6 months postassessment, 12 patients had died and 
by 12 months this had increased to a total of 27 (14.5%) 
patients. Five patients had insufficient data available at 6 
and 12 months (missing documentation). This resulted 
in complete data at 12 months for 154 (83%) patients. 
Given the high proportion of survivors at 12 months, we 
confine the analysis mostly to the 12 months’ data-set.
The median age of the 154 patients was 79 years (range: 
66–100), 90 (58%) were women (median age 80 years) 
and 64 (42%) were men (median age 78 years). These 
demographics were not statistically significantly different 
from those at the time of the assessments shown in table 1. 
At the 12 months’ postassessment, 120 (78%) patients 
were living at home and 34 (22%) in a residential care or 
nursing home. Of those living at home, 51 (33%) were 
living alone and 69 (45%) were cohabiting. All these find-
ings were not statistically significantly different from the 
corresponding proportions at the time of the geriatrician 
assessments. Following the assessments, the geriatricians 
did not receive any direct communication from the GP 
surgeries regarding complications from the recommen-
dations they had made or any requests for other advice.
Medication adherence
Table 3 shows the extent to which the recommendations 
made by the geriatricians were still in place. The rates of 
adherence were 72% at 6 months and 65% at 12 months.
Interactions with healthcare usage
Figure 1 shows the data for the 154 patients who 
completed the 12 months follow-up period. In the two 
6-month periods prior to CGA, the total rates of health-
care episodes requiring services usage were stable. In the 
6 months following the assessment, healthcare services 
usage increased by 132 (37%) and fell slightly thereafter 
that is, by 19 (4%).
A separate descriptive analysis was also performed for 
just emergency episodes during each of the four 6-month 
periods. The emergency group of episodes comprised: GP 
home visits, telephone requests for advice out of normal 
working hours, walk-in primary care centre attendance, 
A&E attendance and hospital admission. In the 12 months 
prior to the CGA, there was an increase of 18 (34%) in 
emergency episodes requiring healthcare services usage. 
In the 6-month period following the CGA, there was a 
further increase by 45 (63%). In the subsequent 6-month 
period a much smaller increase was observed that is, only 
6 (5%) more episodes.
There were increases in total and emergency health-
care episodes and service usage from the baseline period 
to those in the postassessment period. For planned 
admissions, the IRR was 1.23 (1.07, 1.41), entailing a 23% 
increase after the intervention. For unplanned admis-
sions, the IRR was 1.83 (1.43, 2.34), entailing an 83% 
increase. However, these were before–after analyses with 
no independent control group, so it is not known what the 
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Table 3 Medication adherence* at 6 and 12 months 
postassessment
Adherence
Non-
adherence Unknown (%)
6 months 122 (72%) 45 (27%) 2 (1)
12 months 100 (65%) 51 (33%) 3 (2)
*‘Adherence’ defined as drug recommendation still implemented 
post-CGA, including drug type and dosage recommended by 
geriatrician at assessment.
magnitude of change would have been for a comparison 
group which had not received the intervention. An RCT 
would be needed to determine the effects of an interven-
tion. It has been demonstrated, however, that data collec-
tion and analysis are feasible, and preintervention values 
and attrition rates are available to help plan for a full trial.
dIscussIOn
This pilot project demonstrated that CGAs of older 
patients with complex needs, by geriatricians in a general 
practice care setting, were feasible. GPs involved in the 
study reported that they found the intervention by the 
geriatricians both constructive and popular with patients. 
GPs also appreciated the support they received in opti-
mising their patients’ medications. This high level of 
satisfaction by GPs and service users is consistent with the 
favourable feedback observed in other studies of commu-
nity-based holistic assessment and interventions in older 
frail people.13 Furthermore, we demonstrated that the 
computerised clinical systems within general practice 
enabled easy identification of suitable patients for selec-
tion as well as the collection of important clinical data 
to evaluate and compare outcomes. The infrastructure is 
therefore in place for such models of service to be further 
evaluated and implemented in community settings. 
However, this may not necessarily be the case everywhere 
as half of the general practices who were invited to partic-
ipate had declined, hence we cannot exclude the possi-
bility that adequate infrastructure is not in place in those 
practices.
In this study, patients received a holistic assessment 
by specialist geriatricians, but only on one occasion 
and without further involvement. This differs from the 
standard hospital-based CGA that entails concurrent 
involvement of multiple professionals as well as ongoing 
monitoring and reassessments. In a similar, larger study 
of a geriatrician-led outreach service for residents of 
residential homes, patients were additionally offered 
further visits for management of intercurrent problems 
as required.14 In that study, a significant reduction in 
acute hospital admissions was observed after implemen-
tation of the service as compared with a 2-year baseline 
period prior to its commencement. Hence, there seems 
to be merit in community-based geriatric assessments 
with on-going involvement of geriatricians when patients 
become unstable. However, both this study and our 
current study did not include an independent control 
group to enable a rigorous evaluation of the interven-
tion. An ideal study design would involve RCT method-
ology and clearly there is justification for further clinical 
research in community settings. We have also demon-
strated that data collection is feasible, and have been 
able to generate estimates relating to our outcomes, and 
estimates of attrition rates, which can be used in plan-
ning a further study.
Although this study has some limitations, mainly due to 
being a single-arm intervention study, it does appear to 
demonstrate a significant impact on medicines optimisa-
tion, the results of which indicate that a full RCT should 
now be undertaken. On average, four drug alterations 
per patient were recommended. Furthermore, almost 
60% of the alterations comprised cessation of drugs or 
reductions in dosage. The intention of this was to improve 
patient well-being through medicines optimisation and 
rectifying excessive dosages in frail vulnerable patients. 
Additionally, there are obvious cost savings implications 
to these medication changes (not evaluated as part of 
this study) that are worthy of full health economic eval-
uation in a subsequent study. The detrimental effects of 
inappropriate polypharmacy are common and a report 
from The King’s Fund has advised that policy, medical 
training and clinical practice must adopt an approach 
to identify and rectify ‘problematic’ polypharmacy.15 
However, it is important to differentiate ‘appropriate’ 
polypharmacy, that is, when potential benefits outweigh 
potential harms.16 Also, it is important to detect poten-
tial drug omissions denying patients potential benefits. In 
our study, 18% of medication changes represented the 
commencement of a new drug.
The number of emergency/unplanned healthcare 
interactions increased following the CGA (figure 1). 
This continues the trend of increasing healthcare 
usage observed during the two 6-month periods prior 
to the CGA. Increasing healthcare usage (planned and 
unplanned) would be expected to show an increasing 
trend as these frail patients with multiple conditions 
become sicker. The continued increase in unplanned 
healthcare usage in the 6 months following the CGA may 
be due to the time needed for modifications to medica-
tion to be implemented and to take effect. It can be seen 
that in the second 6-month period post-CGA (months 
6–12) the number of unplanned/emergency healthcare 
interactions levels out and does not continue to increase 
in line with the previous 18 months. An independent 
control group, as part of a RCT, would confirm whether 
this observed flattening out in unplanned healthcare 
interactions was due to the CGA.
The geriatricians carried out holistic assessment of the 
patients and not only a medications review. Hence, as 
well as recommending modifications to optimise patient 
medication, geriatricians made further recommenda-
tions for extra investigations, assessments and interven-
tions. This may, in part, explain the increase in planned 
healthcare interactions observed (figure 1) in the first 
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Figure 1 Planned and emergency/unplanned healthcare service usage during 1-year precomprehensive geriatric assessment 
(CGA) and 1-year post-CGA, grouped in 6 monthly periods.
6 months post-CGA and why these decrease in the second 
6-month period.
Given that about 90% of healthcare contacts take place 
in primary care,17 there is much to gain through inter-
ventions to address potentially harmful polypharmacy 
in community settings. To this end, pharmacists can also 
make a valuable contribution as it has been shown that 
they can result in more appropriate prescribing, drug 
cost reductions and reduced healthcare services usage.18 
Another prominent finding regarding medications is that 
rates of adherence to the geriatricians’ recommenda-
tions in our study were high 6 months after assessment 
(72%) and even after 12 months (65%). This suggests 
that amendments were well received by both patients and 
their GPs.
The death rate in our study over a period of 1 year was 
low that is, about 15%. It is not possible to relate this to 
the single comprehensive assessment by a geriatrician. 
Also, the median age of the patients in our study was not 
very high (median men; 78 years, women; 82 years). In 
Hutchinson’s et al study14 the median age was higher, the 
patients were more often acutely ill, and their death rate 
was much higher (73%) over a 4-year period postenrol-
ment to the community-based service. Again, an RCT 
would be the best method to elucidate possible effects of 
innovative community-based services on mortality rates.
The essence of our study was in line with the current 
national drive to move a range of services, traditionally 
provided in hospital settings, into the community.19 20 
Also, our approach was in tune with the recent National 
Institute for Health and Care Excellence Guidance on the 
management of multimorbidity whose recommendations 
include identifying relevant patients proactively by using 
electronic health records, performing CGA and reducing 
pharmacological treatment burden21.
Better communication and cooperation between GPs 
and secondary care specialists has been identified as one 
of the determining factors that lead to improved effec-
tiveness of new community-based services.22 It is there-
fore encouraging that our study and another community 
project in North Staffordshire13 demonstrate a very 
constructive collaboration between GPs and geriatric 
team specialists from secondary care, suggesting that 
further studies and clinical trials are feasible and have 
scope to yield beneficial outcomes.
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